Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 4Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Classical hematology 2

Conditions

Myelodysplastic Syndromes 6Leukemia, Myeloid, Acute 6Multiple Myeloma 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Primary Myelofibrosis 4Leukemia, Myelomonocytic, Chronic 4Leukemia 4Anemia, Refractory, with Excess of Blasts 4Anemia, Aplastic 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Polycythemia Vera 2Myeloproliferative Disorders 2Lymphoma 2Hematologic Neoplasms 2Hematologic Diseases 2Thrombocytopenia 1Thrombocythemia, Essential 1Severe Combined Immunodeficiency 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Lymphoma, Follicular 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1

Interventions

fludarabine phosphate 17Peripheral Blood Stem Cell Transplantation 14Cyclophosphamide 14Busulfan 11Whole-Body Irradiation 10Tacrolimus 8Mycophenolic Acid 8Melphalan 7Cyclosporine 7Methotrexate 6Antilymphocyte Serum 6Filgrastim 5Etoposide 5fludarabine 4Flow Cytometry 3Cytarabine 3Transplantation 2Thiotepa 2Stem Cell Transplantation 2Radiotherapy 2Polymerase Chain Reaction 2Methylprednisolone 2Cytogenetic Analysis 2Cyclosporins 2Cord Blood Stem Cell Transplantation 2Biopsy 2Aspirin 2Alemtuzumab 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2tipifarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Polycythemia Vera × Stem Cell Transplantation × Classical hematology × Clear all
NCT01760655 2025-10-30

Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

Thomas Jefferson University

Phase 2 Completed
62 enrolled 15 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Leukemia, Myeloid, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Polycythemia Vera, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT05031897 2025-10-30

Two Step Haplo With Radiation Conditioning

Thomas Jefferson University

Phase 2 Recruiting
63 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡